Under the title “Toward Adverse Outcome Pathways and Fit-for-Purpose Assays for DNT” the fourth International Conference on Alternatives for Developmental Neurotoxicity Testing (DNT) will be held in Philadelphia, PA, from the 12th until the 14th of May 2014.
The European Union Reference Laboratory for Alternatives to Animal Testing (EURL Ecvam) has released a video on its work on chemical safety assessment without animal testing.
One of the methods used for testing new pharmaceutical substances for their efficacy is on cells in vitro. To that end, scientists led by Stephan Stürwald at the Fraunhofer Institute for Production Technology (IPT) have combined digital holographic microscopy with optical tweezers.
Four researchers based in Tübingen and Stuttgart-Hohenheim will receive funding from the State of Baden-Württemberg for the coming two years for their research on alternatives and complementary methods to animal experiments. The funding totals €400,000.
Prof. Oliver Brüstle and his team of scientists from Bonn, Germany, have developed a new test with which they are able to test the effects of potential Alzheimer's drugs on human brain cells, with the aim of the test is to provide better results than animal experiments.
The coalition agreement from 18 December 2013 between the Christian Democratic Union (CDU) and the Green Party in the State of Hesse contains extensive passages for non-animal research.
A research team led by Prof. Hartmut Geiger of University Hospital Ulm and colleagues from the Cincinnati Children's Hospital Medical Center have discovered that blood stem cells switch pathways in the course of their ageing process.
A "virtual T cell" that shows what happens in blood cells when surface receptor proteins are stimulated Is now available to scientists worldwide.
With the help of a functional magnetic resonance tomograph, researchers led by Dr. Mikolai Axmacher from the German Centre for Neurodegenerative Diseases (DZNE) have investigated a memory performance mechanism.
American scientists have tested a hypothesis that certain types of intestinal bacteria can positively or negatively influence the risk of colorectal cancer (CRC). Sequencing and subsequent analyzes provided new evidence of a possible link.